Kevin Canning is an energetic and strategic scientist and business leader with over 20 years of experience in the pharmaceutical and biotechnology industry. They have led drug development and commercialization across various therapeutic areas, with expertise in pre-clinical development, regulatory affairs, and clinical operations. Kevin has held senior roles at organizations such as AstraZeneca and GlaxoSmithKline, and currently serves as the Head of Development Engagement Strategy for Alexion Pharmaceuticals. They hold an H.B.Sc. from Western University, an MBA from the Richard Ivey School of Business, and have completed multiple postdoctoral fellowships. Passionate about combining science and business, Kevin is committed to developing innovative treatments to improve patient lives while actively mentoring others in their professional growth.
This person is not in the org chart
This person is not in any teams
This person is not in any offices